Ask Our Doctors and Nurses!

DEPAKOTE Side Effect?
Don't put Your Health at Risk - Take Action Now! Type your question here

 letters left

DEPAKOTE Safety Reports

Total DEPAKOTE reports: 274.
DEPAKOTE FDA safety alerts: 2002 .
Reported deaths: 31    Reported hospitalizations: 161.
Take DEPAKOTE Side Effects Survey or Share Your DEPAKOTE Story. Read More Here.

Showing 1-75 of 274 Next >

Health Professional from UNITED STATES reported DEPAKOTE problem on Mar 17, 2006. Female patient, 23 years of age, was diagnosed with epilepsy, hiv infection and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, hepatic function abnormal, jaundice, pruritus. DEPAKOTE dosage: unknown. During the same period patient was treated with REYATAZ, TRILEPTAL. Patient was hospitalized. Patient recovered.

DEPAKOTE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 29, 2006. Male patient, 25 years of age, weighting 200.0 lb, was diagnosed with mental disorder and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: pancreatitis. DEPAKOTE dosage: 500 MG, 4 IN 1 D, PER ORAL. During the same period patient was treated with LORAZEPAM, ZIPRASIDONE. Patient was hospitalized. Patient died on 02/26/2006.

Physician from UNITED STATES reported DEPAKOTE problem on Mar 31, 2006. Male patient, 46 years of age, was diagnosed with bipolar disorder and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: ammonia increased. DEPAKOTE dosage: unknown. Patient was hospitalized. Patient recovered.

DEPAKOTE problem was reported by a Health Professional from UNITED STATES on May 12, 2006. Female patient, 35 years of age, weighting 144.0 lb, was diagnosed with affective disorder, convulsion and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: ammonia increased, neurological symptom, urine analysis abnormal. DEPAKOTE dosage: unknown. During the same period patient was treated with QUETIAPINE, LORAZEPAM, CALCIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported DEPAKOTE problem on June 08, 2006. Female patient, 67 years of age, was diagnosed with bipolar disorder and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. DEPAKOTE dosage: 750 MG, 1IN 1 D, ORAL. Patient was hospitalized. Patient recovered.

DEPAKOTE problem was reported by a Physician from UNITED STATES on June 16, 2006. Male patient, weighting 8.80 lb, was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: talipes. DEPAKOTE dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DEPAKOTE problem on June 21, 2006. Male patient, weighting 7.13 lb, was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: cleft palate, hypospadias. DEPAKOTE dosage: unknown. Patient recovered.

DEPAKOTE problem was reported by a Health Professional from UNITED STATES on July 07, 2006. Male patient, child 10 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: contusion, mania, platelet count decreased, weight decreased. DEPAKOTE dosage: 500 MG Q AM AN D750 MG Q HS, ORAL. During the same period patient was treated with RISPERIDONE, METHYLPHENIDATE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported DEPAKOTE problem on Aug 07, 2006. Male patient, 30 years of age, weighting 346.1 lb, was diagnosed with bipolar disorder, schizoaffective disorder and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: constipation, dyspepsia, pancreatitis. DEPAKOTE dosage: unknown. Patient was hospitalized. Patient died on 08/07/2006.

DEPAKOTE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 14, 2006. Male patient, 22 years of age, weighting 195.0 lb, was diagnosed with psychotic disorder, schizoaffective disorder and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, hypomania, psychotic disorder, somnolence. DEPAKOTE dosage: unknown. During the same period patient was treated with RISPERIDONE, TRAZODONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DEPAKOTE problem on Aug 17, 2006. Male patient, 42 years of age, weighting 269.0 lb, was diagnosed with bipolar disorder and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. DEPAKOTE dosage: 500 MG, 4 IN 1 D, PER ORAL. During the same period patient was treated with LITHIUM CARBONATE. Patient was hospitalized. Patient recovered.

DEPAKOTE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 18, 2006. Male patient, 42 years of age, was diagnosed with convulsion and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: lethargy. DEPAKOTE dosage: 500 MG, 3 IN 1 D, PER ORAL. During the same period patient was treated with PHENYTOIN, LORATADINE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported DEPAKOTE problem on Oct 19, 2006. Female patient, 54 years of age, was diagnosed with pain, multiple sclerosis and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: accidental overdose, vomiting. DEPAKOTE dosage: unknown. During the same period patient was treated with VICODIN, TRAMADOL, LUNESTA, INTERFERON BETA. Patient died on 07/26/2006.

DEPAKOTE problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 18, 2006. Male patient, 69 years of age, was diagnosed with glioblastoma multiforme and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: dyspnoea, hypoxia, lymphopenia, mucosal inflammation, pancytopenia, stomatitis. DEPAKOTE dosage: unknown. During the same period patient was treated with TEMOZOLOMIDE, BACTRIM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DEPAKOTE problem on Dec 06, 2006. Male patient, 29 years of age, weighting 150.0 lb, was diagnosed with convulsion and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, convulsion, decreased appetite. DEPAKOTE dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.

DEPAKOTE problem was reported by a Health Professional from UNITED STATES on Feb 12, 2007. Male patient, 48 years of age, was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: red cell distribution width increased, thrombocythaemia. DEPAKOTE dosage: unknown. During the same period patient was treated with RISPERIDONE, BENZTROPINE MESYLATE. Patient recovered.

Physician from UNITED STATES reported DEPAKOTE problem on Apr 25, 2007. Female patient, weighting 125.1 lb, was diagnosed with epilepsy and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, pancreatitis, pancytopenia. DEPAKOTE dosage: unknown. During the same period patient was treated with CARBAMAZEPINE, ESOMEPRAZOLE MAGNESIUM, RISPERIDONE, SENNA FRUIT, DOCUSATE, CALCIUM CHLORIDE, NIFREXTE. Patient was hospitalized. Patient died on 04/20/2007.

DEPAKOTE problem was reported by a Health Professional from FRANCE on Apr 25, 2007. Female patient, 44 years of age, was diagnosed with epilepsy and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: fall, gamma-glutamyltransferase increased, hepatitis. DEPAKOTE dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported DEPAKOTE problem on Apr 24, 2007. Female patient, 45 years of age, was diagnosed with depression and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased. DEPAKOTE dosage: unknown. During the same period patient was treated with CYMBALTA. Patient recovered.

DEPAKOTE problem was reported by a Physician from UNITED STATES on May 02, 2007. Female patient, weighting 170.2 lb, was diagnosed with convulsion, affective disorder, bipolar disorder and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aggression, concussion, contusion, depression, hepatotoxicity, loss of consciousness, paranoia. DEPAKOTE dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported DEPAKOTE problem on May 07, 2007. Male patient, 52 years of age, weighting 175.0 lb, was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: blood amylase increased, vomiting. DEPAKOTE dosage: unknown. Patient recovered.

DEPAKOTE problem was reported by a Health Professional from FRANCE on May 02, 2007. Female patient, 68 years of age, was diagnosed with bipolar i disorder and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: bradyphrenia, communication disorder, disorientation, encephalopathy, fall, fatigue, hyperammonaemia, hypernatraemia. DEPAKOTE dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported DEPAKOTE problem on May 10, 2007. Male patient, weighting 2.50 lb, was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: congenital foot malformation, lung disorder, premature baby, small for dates baby. DEPAKOTE dosage: unknown. Patient was hospitalized. Patient recovered.

DEPAKOTE problem was reported by a Physician from UNITED STATES on May 10, 2007. Female patient, weighting 3.00 lb, was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: bipolar disorder, emotional disorder, headache, learning disability, mass, premature baby, small for dates baby. DEPAKOTE dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DEPAKOTE problem on May 15, 2007. Male patient, 46 years of age, weighting 160.0 lb, was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: cardiomegaly, diabetes mellitus, diabetic ketoacidosis, prescribed overdose. DEPAKOTE dosage: unknown. During the same period patient was treated with LITHANE, ZYPREXA. Patient died on 03/04/2006.

DEPAKOTE problem was reported by a Health Professional from FRANCE on May 14, 2007. Female patient, 79 years of age, was diagnosed with bipolar i disorder and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: anorexia, thrombocytopenia. DEPAKOTE dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported DEPAKOTE problem on May 16, 2007. Male patient, 53 years of age, was diagnosed with bipolar i disorder and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, pleural effusion, pneumonia, pulmonary embolism. DEPAKOTE dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE, OLANZAPINE. Patient was hospitalized. Patient recovered.

DEPAKOTE problem was reported by a Health Professional from FRANCE on May 15, 2007. Female patient, 54 years of age, was diagnosed with bipolar i disorder, hypertension and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: arrhythmia, cardio-respiratory arrest, coma, condition aggravated, livedo reticularis, miosis, multi-organ failure, mydriasis, overdose. DEPAKOTE dosage: unknown. During the same period patient was treated with AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE. Patient was hospitalized. Patient died on 03/10/2007.

Health Professional from FRANCE reported DEPAKOTE problem on May 21, 2007. Female patient, 43 years of age, was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, cholelithiasis, cytolytic hepatitis, hepatitis cholestatic, jaundice. DEPAKOTE dosage: unknown. Patient was hospitalized. Patient recovered.

DEPAKOTE problem was reported by a Physician from UNITED STATES on May 22, 2007. Female patient, weighting 76.07 lb, was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: atrial septal defect, cleft palate, congenital hydrocephalus, congenital musculoskeletal anomaly, convulsion, developmental delay, foetal anticonvulsant syndrome, joint contracture. DEPAKOTE dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported DEPAKOTE problem on May 29, 2007. Female patient, 51 years of age, was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: heart rate increased, lethargy, loss of consciousness, mental status changes, pyrexia, tremor. DEPAKOTE dosage: 2000MG PO. During the same period patient was treated with SYNTHROID, ENABLEX, MIRAPEX, NEURONTIN, AVINZA, VALIUM, MIRALAX. Patient was hospitalized. Patient recovered.

DEPAKOTE problem was reported by a Physician from FRANCE on May 24, 2007. Male patient, 56 years of age, was diagnosed with bipolar disorder and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: anxiety, asterixis, confusional state, disorientation, encephalopathy, extrapyramidal disorder, muscle rigidity, psychomotor skills impaired. DEPAKOTE dosage: unknown. During the same period patient was treated with TIANEPTINE, LITHIUM CARBONATE, LEVOTHYROXINE, AMISULPRIDE, TRIHEXYPHENIDYL HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported DEPAKOTE problem on May 25, 2007. Female patient, 80 years of age, was diagnosed with bipolar disorder and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: aphasia, dysarthria, mobility decreased, repetitive speech. DEPAKOTE dosage: unknown. During the same period patient was treated with AMLODIPINE, ACETYLSALICYLIC ACID SRT, FUROSEMIDE, INSULIN, LEVOTHYROXINE, LITHIUM CARBONATE. Patient was hospitalized and became disabled. Patient recovered.

DEPAKOTE problem was reported by a Health Professional from FRANCE on May 31, 2007. Female patient, 43 years of age, was diagnosed with mania and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, alopecia, cholelithiasis, cytolytic hepatitis, hepatitis cholestatic, jaundice, rash. DEPAKOTE dosage: unknown. During the same period patient was treated with TRIMEBUTINE MALEATE, MACROGOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from BRAZIL reported DEPAKOTE problem on May 29, 2007. Male patient, weighting 180.8 lb, was diagnosed with aggression, epilepsy, hypothyroidism, prophylaxis against gastrointestinal ulcer, rhinitis and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, acne, aggression, dry mouth, epilepsy, headache, hepatic pain, pruritus, thirst. DEPAKOTE dosage: unknown. During the same period patient was treated with DEPAKOTE ER, DEPAKOTE ER, DEPAKOTE ER, TRILEPTAL, LEVOTHYROXINE, OMEPRAZOLE, BUDESONIDE. Patient recovered.

DEPAKOTE problem was reported by a Physician from UNITED STATES on June 11, 2007. Male patient, weighting 57.45 lb, was diagnosed with bipolar disorder and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: anorexia, asthenia, balance disorder, contusion, hospitalisation, platelet count decreased, vomiting, weight decreased. DEPAKOTE dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DEPAKOTE problem on June 13, 2007. Male patient, 14 years of age, weighting 95.00 lb, was diagnosed with affective disorder, depression and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: aggression, agitation, completed suicide, condition aggravated, depression, irritability, panic attack. DEPAKOTE dosage: unknown. During the same period patient was treated with LEXAPRO. Patient died on 10/18/2004.

DEPAKOTE problem was reported by a Physician from UNITED STATES on June 11, 2007. Female patient, weighting 115.1 lb, was diagnosed with bipolar disorder, attention deficit/hyperactivity disorder, depression, anxiety, contraception and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: abortion induced. DEPAKOTE dosage: unknown. During the same period patient was treated with DEXMETHYLPHENIDATE HYDROCHLORIDE, ESCITALOPRAM OXALATE, ALPRAZOLAM, NUVARING. Patient recovered.

Physician from UNITED STATES reported DEPAKOTE problem on June 06, 2007. Male patient, weighting 185.2 lb, was diagnosed with bipolar i disorder, bipolar disorder, dyspepsia and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: hypothyroidism, somnolence, treatment noncompliance, tremor, weight increased. DEPAKOTE dosage: unknown. During the same period patient was treated with OLANZAPINE, LORAZEPAM, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.

DEPAKOTE problem was reported by a Physician from UNITED STATES on June 06, 2007. Female patient, weighting 230.4 lb, was diagnosed with bipolar i disorder, back pain, mania, insomnia, hypertension and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: ammonia increased, arrhythmia, blood alkaline phosphatase increased, confusional state, gastrointestinal stromal tumour. DEPAKOTE dosage: unknown. During the same period patient was treated with DEPAKOTE ER, TYLOX, OLANZAPINE, CARBAMAZEPINE, LUNESTA, ATENOLOL W. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported DEPAKOTE problem on June 13, 2007. Male patient, 37 years of age, weighting 132.3 lb, was diagnosed with convulsion and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: appendicitis perforated, convulsion. DEPAKOTE dosage: unknown. During the same period patient was treated with DEPACON. Patient was hospitalized. Patient recovered.

DEPAKOTE problem was reported by a Health Professional from FRANCE on June 14, 2007. Male patient, 51 years of age, was diagnosed with mania, diabetes mellitus insulin-dependent and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: ketoacidosis. DEPAKOTE dosage: unknown. During the same period patient was treated with ALIMEMAZINE TARTRATE, OLANZAPINE, INSULIN. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported DEPAKOTE problem on June 18, 2007. Female patient, 41 years of age, was diagnosed with convulsion and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: crying, nodule, palatal disorder, rash papular, somnolence. DEPAKOTE dosage: 1500 MG DAILY PO. Patient recovered.

DEPAKOTE problem was reported by a Health Professional from UNITED STATES on June 18, 2007. Male patient, 59 years of age, was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: mania. DEPAKOTE dosage: unknown. During the same period patient was treated with METFORMIN, LORAZEPAM. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported DEPAKOTE problem on June 15, 2007. Male patient, 69 years of age, was diagnosed with mania and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: hyperthermia, mania, pneumonia aspiration, pulmonary congestion, respiratory distress, respiratory tract congestion, somnolence. DEPAKOTE dosage: unknown. During the same period patient was treated with CYAMEMAZINE, LOXAPINE. Patient was hospitalized. Patient died on 03/11/2007.

DEPAKOTE problem was reported by a Pharmacist from UNITED STATES on June 26, 2007. Male patient, 49 years of age, weighting 224.9 lb, was diagnosed with schizoaffective disorder and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aggression, ammonia increased, lethargy, mental status changes, somnolence, tremor. DEPAKOTE dosage: 1250 MG BID PO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DEPAKOTE problem on June 26, 2007. Female patient, weighting 80.00 lb, was diagnosed with bipolar disorder and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, diabetes mellitus. DEPAKOTE dosage: unknown. During the same period patient was treated with RISPERDAL, ABILIFY. Patient was hospitalized and became disabled. Patient recovered.

DEPAKOTE problem was reported by a Consumer or non-health professional from FRANCE on June 15, 2006. Female patient, 64 years of age, was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: thrombosis. DEPAKOTE dosage: unknown. Patient was hospitalized. Patient died.

Physician from FRANCE reported DEPAKOTE problem on June 15, 2006. Male patient, 41 years of age, was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: cerebral thrombosis, sensory level abnormal. DEPAKOTE dosage: unknown. Patient was hospitalized. Patient recovered.

DEPAKOTE problem was reported by a Physician from UNITED STATES on June 29, 2006. Male patient, 16 years of age, was diagnosed with abnormal behaviour and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: injury. DEPAKOTE dosage: unknown. Patient recovered.

Physician from UNITED STATES reported DEPAKOTE problem on June 28, 2006. Female patient, 62 years of age, was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: convulsion, platelet count decreased, status epilepticus. DEPAKOTE dosage: unknown. During the same period patient was treated with LEVETIRACETAM, LAMOTRIGINE. Patient was hospitalized. Patient died on 06/19/2006.

DEPAKOTE problem was reported by a Consumer or non-health professional from UNITED STATES on July 05, 2006. Male patient, 36 years of age, was diagnosed with suicide attempt and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: coma, overdose, suicide attempt. DEPAKOTE dosage: unknown. During the same period patient was treated with OLANZAPINE, CLONAZEPAM. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported DEPAKOTE problem on July 12, 2006. Male patient, weighting 145.5 lb, was diagnosed with affective disorder and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, fatigue, leukopenia, thrombocytopenia. DEPAKOTE dosage: 500 MG BID PO. During the same period patient was treated with TRILEPTAL. Patient recovered.

DEPAKOTE problem was reported by a Health Professional from FRANCE on July 07, 2006. Female patient, 20 years of age, was diagnosed with schizophrenia and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: photodermatosis. DEPAKOTE dosage: unknown. During the same period patient was treated with CYAMEMAZINE, ALPRAZOLAM, HYDROXYZINE HYDROCHLORIDE, ARIPIPRAZOLE, OLANZAPINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported DEPAKOTE problem on Feb 21, 2006. Female patient, 43 years of age, was diagnosed with intentional overdose and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: amnesia, coma, intentional overdose, respiratory distress. DEPAKOTE dosage: unknown. During the same period patient was treated with ALPRAZOLAM, MIRTAZAPINE, AZATHIOPRINE. Patient was hospitalized and became disabled. Patient recovered.

DEPAKOTE problem was reported by a Physician from FRANCE on June 23, 2006. Female patient, 76 years of age, was diagnosed with affective disorder and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, cerebral atrophy, dementia, gait disturbance, leukoaraiosis, leukopenia, memory impairment, mutism, parkinsonism. DEPAKOTE dosage: unknown. During the same period patient was treated with ZOLPIDEM TARTRATE, VENLAFAXINE, GINKOR, ZOCOR, GINKGO TREE LEAVES, ASPIRIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DEPAKOTE problem on July 05, 2006. Male patient, weighting 229.3 lb, was diagnosed with suicide attempt, bipolar disorder, pain and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: coma, intentional overdose, suicide attempt. DEPAKOTE dosage: unknown. During the same period patient was treated with OLANZAPINE, CLONAZEPAM, CYCLOBENZAPRINE, VICODIN. Patient was hospitalized. Patient recovered.

DEPAKOTE problem was reported by a Physician from UNITED STATES on July 20, 2006. Female patient, 26 years of age, was diagnosed with schizophrenia and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: convulsion, hallucination. DEPAKOTE dosage: unknown. During the same period patient was treated with CLOZARIL. Patient recovered.

Physician from FRANCE reported DEPAKOTE problem on July 20, 2006. Female patient, 73 years of age, was diagnosed with bipolar disorder, cardiac failure and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: cardiac failure, oedema peripheral, weight increased. DEPAKOTE dosage: unknown. During the same period patient was treated with OLANZAPINE, CYAMEMAZINE, OXAZEPAM, OMEPRAZOLE, NULYTELY, VELITEN, DIURETICS. Patient recovered.

DEPAKOTE problem was reported by a Health Professional from BRAZIL on July 21, 2006. Female patient, 36 years of age, was diagnosed with bipolar disorder and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. DEPAKOTE dosage: unknown. During the same period patient was treated with FLUOXETINE. Patient recovered.

Physician from UNITED STATES reported DEPAKOTE problem on July 07, 2006. Female patient was diagnosed with epilepsy, contraception and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: raynaud's phenomenon, scleroderma. DEPAKOTE dosage: unknown. Patient was hospitalized. Patient recovered.

DEPAKOTE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 01, 2006. Female patient, 50 years of age, was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: haemolysis, renal failure acute, suicide attempt. DEPAKOTE dosage: unknown. During the same period patient was treated with TRAZODONE, PAROXETINE HYDROCHLORIDE, TOLTERODINE TARTRATE, RISPERIDONE, DOXYCYCLINE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported DEPAKOTE problem on Aug 07, 2006. Female patient was diagnosed with depression and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: dysarthria, performance status decreased, somnolence, vision blurred. DEPAKOTE dosage: 3 X 500 MG -1500 MG- QD PO. Patient recovered.

DEPAKOTE problem was reported by a Health Professional from UNITED STATES on Aug 03, 2006. Male patient, 24 years of age, was diagnosed with bipolar disorder and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, mania, pruritus, skin exfoliation. DEPAKOTE dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported DEPAKOTE problem on Aug 11, 2006. Female patient, 32 years of age, weighting 161.0 lb, was diagnosed with bipolar i disorder and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: dizziness, feeling abnormal, hyperammonaemia. DEPAKOTE dosage: 1000 MG DAILY PO. Patient recovered.

DEPAKOTE problem was reported by a Physician from FRANCE on Aug 04, 2006. Female patient, 55 years of age, was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, liver function test abnormal, oedema. DEPAKOTE dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DEPAKOTE problem on Aug 14, 2006. Female patient, 47 years of age, weighting 127.0 lb, was diagnosed with epilepsy and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: alopecia, amnesia, bone disorder, condition aggravated, convulsion, heart rate irregular, musculoskeletal chest pain, nervousness, tooth loss. DEPAKOTE dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.

DEPAKOTE problem was reported by a Physician from FRANCE on July 20, 2006. Female patient, weighting 185.2 lb, was diagnosed with bipolar disorder, insomnia, gastrooesophageal reflux disease, constipation, venous insufficiency, cardiac failure and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: atrial hypertrophy, cardiac murmur, dyspnoea, dyspnoea exertional, gamma-glutamyltransferase increased, hepatic pain, hepatojugular reflux, hepatomegaly, hyponatraemia. DEPAKOTE dosage: unknown. During the same period patient was treated with OLANZAPINE, CYAMEMAZINE, OXAZEPAM, OMEPRAZOLE, NULYTELY, VELITEN, DIURETICS. Patient recovered.

Physician from FRANCE reported DEPAKOTE problem on July 20, 2006. Female patient, weighting 185.2 lb, was diagnosed with bipolar disorder, insomnia, gastrooesophageal reflux disease, constipation, venous insufficiency, cardiac failure and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: atrial hypertrophy, cardiac murmur, dyspnoea, dyspnoea exertional, gamma-glutamyltransferase increased, hepatic pain, hepatojugular reflux, hepatomegaly, hyponatraemia. DEPAKOTE dosage: unknown. During the same period patient was treated with OLANZAPINE, CYAMEMAZINE, OXAZEPAM, OMEPRAZOLE, NULYTELY, VELITEN, DIURETICS. Patient recovered.

DEPAKOTE problem was reported by a Health Professional from FRANCE on Aug 11, 2006. Male patient, 54 years of age, was diagnosed with abnormal behaviour and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, hypotension, respiratory distress. DEPAKOTE dosage: unknown. During the same period patient was treated with DIPOTASSIUM CLORAZEPATE, DIPOTASSIUM CLORAZEPATE, TIAPRIDE, ASPIRIN, NULYTELY, PRAVASTATIN, VALPROMIDE. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported DEPAKOTE problem on Aug 11, 2006. Male patient, 54 years of age, was diagnosed with abnormal behaviour and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, hypotension, respiratory distress. DEPAKOTE dosage: unknown. During the same period patient was treated with DIPOTASSIUM CLORAZEPATE, DIPOTASSIUM CLORAZEPATE, TIAPRIDE, ASPIRIN, NULYTELY, PRAVASTATIN, VALPROMIDE. Patient was hospitalized. Patient recovered.

DEPAKOTE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 16, 2006. Female patient, weighting 45.00 lb, was diagnosed with epilepsy and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: convulsion. DEPAKOTE dosage: 375 MG AM PO 500 MG PM PO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DEPAKOTE problem on Aug 09, 2006. Male patient, weighting 145.1 lb, was diagnosed with convulsion, anxiety and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: convulsion. DEPAKOTE dosage: unknown. During the same period patient was treated with FLUOXETINE HYDROCHLORIDE, LORAZEPAM. Patient was hospitalized. Patient recovered.

DEPAKOTE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 09, 2006. Female patient, weighting 160.1 lb, was diagnosed with affective disorder and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: gallbladder disorder, heart rate irregular, liver disorder, nail discolouration, ocular icterus, skin discolouration, yellow skin. DEPAKOTE dosage: 500MG 3 IN 1 DAY; 250MG 1 IN 1 DAY. During the same period patient was treated with RISPERIDONE, ZIPRASIDONE. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported DEPAKOTE problem on Aug 15, 2006. Female patient, 56 years of age, was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, c-reactive protein increased, gamma-glutamyltransferase increased, leukopenia, pyrexia, thrombocytopenia. DEPAKOTE dosage: unknown. Patient was hospitalized. Patient recovered.

Showing 1-75 of 274 Next >